These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 232648)

  • 21. Mechanism of control of skeletal-muscle contraction by dantrolene sodium.
    Ellis KO; Carpenter JF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):362-9. PubMed ID: 4368898
    [No Abstract]   [Full Text] [Related]  

  • 22. Early structural changes in the motor nerve terminals of rat skeletal muscle after local injection of botulinum toxin [proceedings].
    Duxson MJ; Stolkin C
    J Physiol; 1979 Nov; 296():12P. PubMed ID: 529073
    [No Abstract]   [Full Text] [Related]  

  • 23. Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission.
    Simpson LL
    Neuropharmacology; 1971 Nov; 10(6):673-84. PubMed ID: 4331443
    [No Abstract]   [Full Text] [Related]  

  • 24. On the mode of action of botulinum toxin.
    Leander S; Thesleff S
    Acta Physiol Scand; 1980 Feb; 108(2):195-6. PubMed ID: 6246722
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of guanidine and germine on the neuromuscular block of botulism.
    Cherington M; Soyer A; Greenberg H
    Curr Ther Res Clin Exp; 1972 Feb; 14(2):91-4. PubMed ID: 4335307
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of axon flow in the mechanism of changes in the properties of skeletal muscle myocytes].
    Mikhaĭlov VV
    Fiziol Zh SSSR Im I M Sechenova; 1980 Nov; 66(11):1711-5. PubMed ID: 6160061
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo study of mechanism of propranolol-induced blockade or neuromuscular transmission.
    Patel VK; Jindal MN; Kelkar VV
    Indian J Physiol Pharmacol; 1974; 18(2):126-8. PubMed ID: 4370094
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of tetrodotoxin-inactive nerve on electrical parameters of rat skeletal muscle.
    Camerino DC; Bryant SH; Megna GF
    Birth Defects Orig Artic Ser; 1983; 19(4):529-33. PubMed ID: 6307417
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscle of the mouse.
    Tonge DA
    J Physiol; 1974 Aug; 241(1):127-39. PubMed ID: 4371301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of acute and chronic botulinum toxin treatment on receptor number, receptor distribution and tissue sensitivity in rat diaphragm.
    Simpson LL
    J Pharmacol Exp Ther; 1977 Feb; 200(2):343-51. PubMed ID: 839441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions.
    Comella JX; Molgo J; Faille L
    Neurosci Lett; 1993 Apr; 153(1):61-4. PubMed ID: 8390032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of H2 receptor antagonists on neuromuscular transmission.
    Bossa R; Chiericozzi M; Efstathiu G; Galatulas I; Ninci MA
    In Vivo; 1991; 5(1):57-9. PubMed ID: 1681958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alpha,alpha'-bis-(dimethylammoniumacetaldehyde diethylacetal)-p,p'-diacetylbiphenyl bromide (DMAE) on neuromuscular transmission.
    Chiou CY; Long JP
    J Pharmacol Exp Ther; 1969 Jun; 167(2):344-50. PubMed ID: 4306905
    [No Abstract]   [Full Text] [Related]  

  • 34. Action of pyridine-2-aldoxime methochloride (PAM) on neuromuscular transmission in vitro and in vivo.
    Goyer GR
    Can J Physiol Pharmacol; 1968 Sep; 46(5):757-64. PubMed ID: 4300713
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of serotonin on neuromuscular transmission in normal guinea pigs and those treated with paralyzing doses of botulinum toxin type A].
    Tazieff-Depierre F
    C R Acad Hebd Seances Acad Sci D; 1978 Mar; 286(10):793-5. PubMed ID: 417868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine.
    Lundh H; Leander S; Thesleff S
    J Neurol Sci; 1977 May; 32(1):29-43. PubMed ID: 194021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission.
    Meunier FA; Schiavo G; Molgó J
    J Physiol Paris; 2002; 96(1-2):105-13. PubMed ID: 11755789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction between divalent cations and botulinum toxin type A in the paralysis of the rat phrenic nerve-hemidiaphragm preparation.
    Simpson LL
    Neuropharmacology; 1973 Feb; 12(2):165-76. PubMed ID: 4362622
    [No Abstract]   [Full Text] [Related]  

  • 39. Maculotoxin, a potent toxin secreted by Octopus maculosus Hoyle.
    Freeman SE TURNER RJ
    Toxicol Appl Pharmacol; 1970 May; 16(3):681-90. PubMed ID: 4316261
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term effects of botulinum toxin on neuromuscular function.
    Frick CG; Richtsfeld M; Sahani ND; Kaneki M; Blobner M; Martyn JA
    Anesthesiology; 2007 Jun; 106(6):1139-46. PubMed ID: 17525589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.